首页> 外文期刊>Bulletin of pharmaceutical sciences >SYNTHESIS OF NOVEL PYRAZOLE DERIVATIVES BEARING 1,2,4-TRIAZOLE MOIETY AS POTENTIAL ANTICANCER AGENTS
【24h】

SYNTHESIS OF NOVEL PYRAZOLE DERIVATIVES BEARING 1,2,4-TRIAZOLE MOIETY AS POTENTIAL ANTICANCER AGENTS

机译:含有1,2,4-三唑部分的新型吡唑衍生物作为潜在抗癌剂的合成

获取原文
获取原文并翻译 | 示例
           

摘要

A series of novel 3-(1H-pyrazol-3-yl)-4H-1,2,4-thazole derivatives were synthesized and the structure of the prepared compounds was fully characterized by ~1H NMR, ~(13)C NMR, and HRESI-MS. Six of the prepared compounds were screened for in-vitro cytotoxicity against different cancer cell lines at National Cancer Institute (NCI), USA. Compound 7e exhibited a broad-spectrum of anticancer activity against different cancer cell lines without pronounced selectivity. Moreover, the anticancer activity of the prepared compounds was also evaluated against different human cancer cell lines including breast MCF-7, lung A549 as well as the human normal melanocyte (HFB4) using doxorubicin as a reference drug. Compounds 71 and 7o exhibited remarkable anticancer activity similar to or more potent than doxorubicin against breast MCF-7 and Lung AS49 cell lines.E-mail: mhamedl02004@yahoo.com
机译:合成了一系列新的3-(1H-吡唑-3-基)-4H-1,2,4-苯唑衍生物,并通过〜1H NMR,〜(13)C NMR, 和hresi-ms。 在美国国家癌症研究所(NCI)的不同癌细胞系中,筛选出六种制备的化合物对不同癌细胞系的体外细胞毒性。 化合物7E在没有明显的选择性的情况下表现出对不同癌细胞系的广谱抗癌活性。 此外,还使用多柔比星作为参考药物,对包括乳腺MCF-7,肺A549以及人普通黑肾(HFB4)的不同人癌细胞系评价制备的化合物的抗癌活性。 化合物71和7o表现出与乳腺MCF-7和肺部AS49细胞系的多柔比星相似的显着抗癌活性。-MHAMEDL02004@yahoo.com

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号